Pharmacy, Natural & Health Sciences

Pharmacogenomics - Welcome from the Program Director


Thank you for taking time to learn more about MU's Pharmacogenomics Programs.

Pharmacogenomics (PGx), the study of a patient’s response to medications relative to their genetics is a rapidly expanding component of precision medicine. The ability to look at an individual’s DNA and use that information to guide drug and/or drug dose selection can lead to more successful treatment, and reduce adverse drug events. Approximately 50% of patients do not respond optimally to the first drug they receive for a given need. Additionally, over the last few years, we have seen an increase in the number of serious adverse drug events, with approximately 1,000,000 serious events and 180,000 deaths annually. Clearly, there is a role for pharmacogenomics in improving and optimizing patient medication therapy.

Manchester University has recognized the need for education of applied scientists and clinicians in PGx. In doing so, the University has designed rigorous, innovative PGx programs. The Master of Science in Pharmacogenomics (MS in PGx) program is a comprehensive program aimed to produce the applied scientist with opportunities for careers in the PGx laboratory industry, translational companies, and healthcare systems. The Graduate Certificate in Pharmacogenomics (GC in PGx) is aimed at clinicians, to help them optimize drug therapy and hone their pharmacotherapy expertise. The MS in PGx is provided in two delivery options, on-campus or online, while the GC in PGx is available online. The programs underwent an extensive application process and are approved by the Higher Learning Commission.

Those who complete the MS in PGx or GC in PGx are individuals of ability and conviction who will benefit society through the application of pharmacogenomics in precision medicine. Manchester University is pleased to offer these programs and contribute to improving health care.

Thank you for visiting the Manchester website and for your interest in the MS in PGx or GC in PGx program!

We invite you to explore the information presented here and contact us with any questions by emailing PGx@manchester.edu or by calling our Office of Admissions and Enrollment Management at 260-470-2703.


David_Kisor_Signature

 

 

David F. Kisor, BS, PharmD

Director of Pharmacogenomics

Mission

The Master of Science in Pharmacogenomics Program and Graduate Certificate in Pharmacogenomics graduates individuals of ability and conviction who benefit society through the application of pharmacogenomics in precision medicine.


Accreditation

The Manchester University Master of Science in Pharmacogenomics Program and Graduate Certificate in Pharmacogenomics are accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools.



Non-Discrimination in the
Admission Process
The Manchester University Pharmacogenomics Program is committed to non-discrimination in the admissions process.The University does not discriminate on the basis of national origin, ancestry, race, color, age, sex, gender identity or expression, sexual orientation, familial status, religion, disability, physical characteristics, or veteran status in admissions including its admission decisions and scholarships or loan awards.